Key result
rAAV-mediated Decorin gene delivery significantly reduced cardiac fibrosis and improved hemodynamics, including decreased left ventricular end-diastolic pressure (p < 0.05), in hypertensive rats.
Why the study?
Does Decorin gene delivery reduce cardiac fibrosis and improve cardiac function in spontaneously hypertensive rats?
Population
5-month-old male spontaneously hypertensive rats (SHRs)
Comparison
Decorin gene delivery by a recombinant… vs Control animals
Design
Preclinical
Follow-up
16 weeks
Authors
Loading...
Supports Decorin gene therapy for fibrosis; hypothesis-generating and leaves open human translation.
Does Decorin gene delivery reduce cardiac fibrosis and improve cardiac function in spontaneously hypertensive rats?
p-value: p=<0.05
Decorin gene delivery via rAAV vector inhibits hypertension-induced cardiac fibrosis and hypertrophy while improving cardiac function in a rat model, highlighting its therapeutic potential for organ fibrosis.
Yan et al. (2009) studied Cardiac fibrosis and hypertension. rAAV-DCN vector (Decorin gene delivery) vs. Control animals was evaluated on Hemodynamics (left ventricular end-diastolic pressure) and cardiac fibrosis (p=<0.05). rAAV-mediated Decorin gene delivery significantly reduced cardiac fibrosis and improved hemodynamics, including decreased left ventricular end-diastolic pressure (p < 0.05), in hypertensive rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: